BRAF and ganglioglioma: Importantly, BRAF alterations (V600E mutations and KIAA1549-BRAF fusions) were distributed across multiple diagnostic groups—PLNTY, ganglioglioma, and pilocytic astrocytoma—each of which exhibited a distinct methylation signature.